Ray Dalio Optimize Rx Corp Transaction History

Bridgewater Associates, LP

  • $17.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$13.74 - $30.13 $370,045 - $811,461
-26,932 Reduced 58.38%
19,197 $284,000
Q2 2022

Aug 11, 2022
BUY
$21.94 - $40.49 $65,710 - $121,267
2,995 Added 6.94%
46,129 $1.26 Million
Q1 2022

May 13, 2022
BUY
$35.27 - $62.91 $368,007 - $656,402
10,434 Added 31.91%
43,134 $1.63 Million
Q4 2021

Feb 14, 2022
BUY
$53.57 - $98.0 $222,315 - $406,700
4,150 Added 14.54%
32,700 $2.03 Million
Q3 2021

Nov 12, 2021
BUY
$50.93 - $85.55 $1.45 Million - $2.44 Million
28,550 New
28,550 $2.44 Million

Others Institutions Holding OPRX

# of Institutions
90
Shares Held
13M
Call Options Held
800
Put Options Held
18.1K
View Full List

About OptimizeRx Corp

OPRX Quotes by TradingView
  • Ticker OPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 18,023,100
  • Market Cap $102M
  • Description
  • OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...
More about OPRX
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email